Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
28.61
+2.61 (10.04%)
At close: Dec 9, 2025
TEVJF Market Cap
TEVJF has a market cap or net worth of $37.45 billion as of January 15, 2026. Its market cap has increased by 44.95% in one year.
Market Cap
37.45B
Enterprise Value
52.34B
Revenue
16.78B
Ranking
n/a
PE Ratio
52.52
Stock Price
$28.61
Market Cap Chart
Since June 26, 1992, TEVJF's market cap has increased from 588.88M to 37.45B, an increase of 6,259.02%. That is a compound annual growth rate of 13.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 37.45B | 4.58% |
| Dec 31, 2025 | 35.81B | 43.19% |
| Dec 31, 2024 | 25.01B | 113.68% |
| Dec 29, 2023 | 11.70B | 15.54% |
| Dec 30, 2022 | 10.13B | 14.65% |
| Dec 31, 2021 | 8.84B | -16.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 811.81M |
| Glass House Brands | 738.79M |
| Elite Pharmaceuticals | 515.71M |
| Northwest Biotherapeutics | 440.23M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 338.05M |
| Silence Therapeutics | 279.15M |